Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

00:00

Preventing CMV Disease and CMV High Risk in Solid Organ Transplants

La Termivir has a lot of advantages over Valgan cycle beer in that it's not renal dose adjusted and it doesn't cause myelosopression or myelotoxicity. The negative side to La Termivir is it doesn't have any HSV or VZV activity. But all in all, it seems like a pretty promising compound for CMV, but it was only approved in cell transplantation up to this point.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app